Utilising Palliative Care Expertise in Critically Ill Patients: Opportunities to Improve Outcomes and Experiences.

Publication date: Jun 16, 2025

Background: Prior to the COVID-19 pandemic, the mortality of patients admitted to intensive care units (ICUs) in the UK reached 20%. Studies show up to 40% of these patients may have been eligible for palliative care (PC) referral on admission to the ICU. The involvement of PC teams improves the quality of care delivered and improves patient and family satisfaction. Several trigger tools have been developed to identify ICU patients most likely to benefit from palliative care; however, no consensus exists regarding the most effective tool. Methods: We conducted a retrospective study to identify the number of PC referrals, prior to death in a general ICU setting over a 7-month period in 2019. For patients not referred to PC, three separate “trigger tools”, previously described in the literature, were retrospectively applied to explore the potential impact each tool may potentially have had on PC referral rates. Results: We identified 121 ICU deaths, of which 28 patients (23%) were referred to PC during their admission to the ICU. After retrospective application of the trigger tools to those who were not referred, 75% (n = 70) of patients triggered at least one criterion using the “Zalenski et al. ” tool and 71% (n = 66) of patients were eligible for referral had the “Hua et al. ” tool had been used. Overall, 82% (n = 36) of cancer patients met at least one criterion for referral with the Royal Marsden tool. Conclusions: Our study supports a finding of poor utilisation of PC services in an ICU patient population. The use of trigger tools can be used to significantly increase the number of appropriate PC referrals in an intensive care setting and may be useful in predicting those who may die. The benefit of PC intervention is aimed at providing holistic support to both patient and family and is associated with better patient and family experience towards the end of life.

Open Access PDF

Concepts Keywords
Mortality intensive care
Pc palliative care
Satisfaction trigger tools
Therapy

Semantics

Type Source Name
disease MESH Critically Ill
disease MESH COVID-19 pandemic
disease IDO quality
disease MESH death
disease MESH cancer
drug DRUGBANK Methionine
disease IDO intervention
drug DRUGBANK Tropicamide
disease MESH causes
disease MESH Chronic diseases
disease MESH relapses
disease MESH frailty
disease IDO symptom
disease MESH emergencies
disease IDO process
disease MESH cardiac arrest
disease IDO facility
disease MESH Anorexia
disease MESH psychological distress
disease MESH respiratory failure
disease MESH sepsis
disease MESH confusion
drug DRUGBANK Etoperidone
drug DRUGBANK Coenzyme M
drug DRUGBANK Hydroxyethyl Starch
drug DRUGBANK Cytidine-5′-Monophosphate

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *